|
Today's Headlines
The majority of antibiotics prescribed for adults in ambulatory care settings are broad-spectrum agents, most commonly fluoroquinolones and macrolides. These are frequently prescribed for conditions where no antibiotic therapy is needed at all, such as for bronchitis and colds, which are caused by viruses, according to a study published online July 25, 2013, in the Journal of Antimicrobial Chemotherapy. » Full article
|
|
Despite last season’s flu outbreak, less than half the people surveyed (46%) by CVS/pharmacy said they were more likely to get a flu shot this year. » Full article
|
|
Drug evaluation and selection models are changing. Safety and efficacy have become the starting point for consideration by many payers. What they really want to see is evidence of superior performance in real-world patient populations. » Full article
|
|
Drug labels and Medication Guides for all fluoroquinolone antibacterial drugs should be updated to better describe the serious side effect of peripheral neuropathy, a nerve disorder occurring in the arms or legs, according to an FDA Drug Safety Communication. The nerve damage, which may occur shortly after these drugs are taken, could be permanent. » Full article
|
Continuing Education
The fifth Pain Management CPE activity, “Management of common pain medications encountered by pharmacists,” is available. It is the final article in our CPE series: Pain Management Considerations in Medication Therapy Management. Pharmacists can earn up to 10 credits by completing our April 2013 through August 2013 monthly knowledge-based activities.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide
or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at
www.MyCPEmonitor.net. This profile will enable you to have one login
for all the NABP programs and services you will need throughout your career.
|
|
EDITOR'S PICK
 Results from a health economic and outcomes research (HECOR) simulation analysis show that canagliflozin (Invokana, Janssen), along with lifestyle management, may reduce long-term complications and associated costs for adult patients with type 2 diabetes compared to a treatment sequence without canagliflozin. » Full article
|
|
|
SURVEY
— Orals will become the most frequently prescribed products
— Injectables will continue to dominate market share
— Equal split between orals and injectables
Click Here to let us know.
|
|
Like
Tweet
